The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1405158 · Cited by 2,249
Cost-Effectiveness in Health and Medicine
(2016) · doi:10.1093/acprof:oso/9780190492939.001.0001 · Cited by 1,552
Research works printed but not linked: 49
- Kaplan, 1982, Health-related quality of life measurement for evaluation research and policy analysis, Health Psychol, 1, 61, 10.1037/0278-6133.1.1.61 · DOI · Paper page
- Laupacis, 1992, How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations, CMAJ, 146, 473
- Bridges, 2010, Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US, Pharmacoeconomics, 28, 175, 10.2165/11530650-000000000-00000 · DOI
- Ryen, 2015, The willingness to pay for a quality adjusted life year: a review of the empirical literature, Health Econ, 24, 1289, 10.1002/hec.3085 · DOI · Paper page
- Bobinac, 2010, Willingness to pay for a quality-adjusted life-year: the individual perspective, Value Health, 13, 1046, 10.1111/j.1524-4733.2010.00781.x · DOI
- Birch, 1993, Changing the problem to fit the solution: Johannesson and Weinstein’s (mis) application of economics to real world problems, J Health Econ, 12, 469, 10.1016/0167-6296(93)90006-Z · doi:10.1016/0167-6296(93)90006-z
- Birch, 2006, The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold, J Health Serv Res Policy, 11, 46, 10.1258/135581906775094235 · DOI
- Gafni, 2006, Incremental cost-effectiveness ratios (ICERs): the silence of the lambda, Soc Sci Med, 62, 2091, 10.1016/j.socscimed.2005.10.023 · DOI · Paper page
- Mccabe, 2008, Cost-effectiveness threshold: what it is and what that means, Pharmacoeconomics, 26, 733, 10.2165/00019053-200826090-00004 · DOI · Paper page
- Eichler, 2004, Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?, Value Health, 7, 518, 10.1111/j.1524-4733.2004.75003.x · DOI · Paper page
- Phelps, 1991, On the (near) equivalence of cost-effectiveness and cost-benefit analyses, Int J Technol Assess Health Care, 7, 12, 10.1017/S0266462300004803 · DOI · Paper page
- Baker, 2011, Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE, Health Econ Policy Law, 6, 435, 10.1017/S1744133111000181 · DOI
- Claxton, 2015, Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold, Health Technol Assess, 19, 1, 10.3310/hta19140 · DOI · Paper page
- Culyer, 2007, Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence, J Health Serv Res Policy, 12, 56, 10.1258/135581907779497567 · DOI · Paper page
- Mason, 2009, Modelling the monetary value of a QALY: a new approach based on UK data, Health Econ, 18, 933, 10.1002/hec.1416 · doi:10.1002/hec.1416
- Blumenschein, 1998, Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma, Ann Allergy Asthma Immunol, 80, 189, 10.1016/S1081-1206(10)62954-7 · DOI
- Zethraeus, 1998, Willingness to pay for hormone replacement therapy, Health Econ, 7, 31, 10.1002/(SICI)1099-1050(199802)7:1<31::AID-HEC316>3.0.CO;2-7 · doi:10.1002/(sici)1099-1050(199802)7:1<31::aid-hec316>3.0.co;2-7
- Cunningham, 2000, Relationship between utility values and willingness to pay in patients undergoing orthognathic treatment, Community Dent Health, 17, 92
- Gyrd-Hansen, 2003, Willingness to pay for a QALY, Health Econ, 12, 1049, 10.1002/hec.799 · DOI · Paper page
- Byrne, 2005, Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis, Med Decis Making, 25, 655, 10.1177/0272989X05282638 · DOI
- King, 2005, Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation, Med Decis Making, 25, 667, 10.1177/0272989X05282640 · DOI · Paper page
- Pinto Prades, 2005, Estimacion del valor monetario de los anos de vida ajustados por calidad: Estimaciones preliminares, Ekonomiaz, I, 192, 10.69810/ekz.0773 · doi:10.69810/ekz.0773
- Lieu, 2009, Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster, Pharmacoeconomics, 27, 1005, 10.2165/11314000-000000000-00000 · DOI
- Pinto-Prades, 2009, Trying to estimate a monetary value for the QALY, J Health Econ, 28, 553, 10.1016/j.jhealeco.2009.02.003 · DOI
- Shiroiwa, 2010, International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?, Health Econ, 19, 422, 10.1002/hec.1481 · DOI · Paper page
- Baker, 2010, Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project, Health Technol Assess., 14, 1, 10.3310/hta14270 · DOI · Paper page
- Donaldson, 2011, The social value of a QALY: raising the bar or barring the raise?, BMC Health Serv Res, 11, 8, 10.1186/1472-6963-11-8 · doi:10.1186/1472-6963-11-8
- Zhao, 2011, Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making?: results from a study in patients with chronic prostatitis, Med Care, 49, 267, 10.1097/MLR.0b013e31820192cd · doi:10.1097/mlr.0b013e31820192cd
- Soini, 2012, Contingent Valuation of Eight New Treatments: What is the Clinician’s and Politician’s Willingness to Pay?, Open Complement Med J, 4, 1, 10.2174/1876391X01204010001 · DOI
- Shiroiwa, 2013, WTP for a QALY and health states: More money for severer health states?, Cost Eff Resour Alloc, 11, 22, 10.1186/1478-7547-11-22 · DOI
- Bobinac, 2013, Valuing qaly gains by applying a societal perspective, Health Econ, 22, 1272, 10.1002/hec.2879 · DOI
- Thavorncharoensap, 2013, Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?, Clinicoecon Outcomes Res, 5, 29, 10.2147/CEOR.S38062 · DOI
- Robinson, 2013, Estimatinga WTP-based value of a QALY: the “chained” approach, Soc Sci Med, 92, 92, 10.1016/j.socscimed.2013.05.013 · DOI
- Pennington, 2013, Comparing WTP values of different types of QALY gain elicited from the general public, Health Econ, 24, 280, 10.1002/hec.3018 · DOI
- Bobinac, 2014, The value of a QALY: individual willingness to pay for health gains under risk, Pharmacoeconomics, 32, 75, 10.1007/s40273-013-0110-1 · DOI
- Martín-Fernández, 2014, Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences, BMC Health Serv Res, 14, 287, 10.1186/1472-6963-14-287 · DOI
- Bobinac, 2012, Get more, pay more? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation, J Health Econ, 31, 158, 10.1016/j.jhealeco.2011.09.004 · DOI
- Gyrd-Hansen, 2012, Disentangling WTP per QALY data: different analytical approaches, different answers, Health Econ, 21, 222, 10.1002/hec.1709 · doi:10.1002/hec.1709
- Haninger, 2011, Diminishing willingness to pay per quality-adjusted life year: valuing acute foodborne illness, Risk Anal, 31, 1363, 10.1111/j.1539-6924.2011.01617.x · DOI
- Hirth, 2000, Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard, Med Decis Mak, 20, 332, 10.1177/0272989X0002000310 · DOI · Paper page
- Towse, 2009, Should NICE’s threshold range for cost per QALY be raised? Yes, BMJ, 338, b181, 10.1136/bmj.b181 · DOI
- Appleby, 2009, Searching for cost effectiveness thresholds in the NHS, Health Policy, 91, 239, 10.1016/j.healthpol.2008.12.010 · DOI
- George, 2001, Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991 to 1996), Pharmacoeconomics, 19, 1103, 10.2165/00019053-200119110-00004 · DOI · Paper page
- Devlin, 2004, Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis, Health Econ, 13, 437, 10.1002/hec.864 · DOI · Paper page
- Chambers, 2010, Does Medicare have an implicit cost-effectiveness threshold?, Med Decis Making, 30, E14, 10.1177/0272989X10371134 · DOI
- Nimdet, 2015, A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?, PLoS One, 10, e0122760, 10.1371/journal.pone.0122760 · DOI
- Lichtenberg, 2004, Sources of U.S. longevity increase, 1960–2001, Q Rev Econ Financ, 44, 369, 10.1016/j.qref.2004.05.005 · DOI
- Martin, 2008, Does health care spending improve health outcomes? Evidence from English programme budgeting data, J Health Econ, 27, 826, 10.1016/j.jhealeco.2007.12.002 · DOI · Paper page
- Martin, 2012, Comparing costs and outcomes across programmes of health care, Health Econ, 21, 316, 10.1002/hec.1716 · DOI
Cited by
Ochalek, J., Lomas, J., & Claxton, K. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2018-000964 · Cited by 334
Healthy Eating and Active Lifestyles: Best Practices in Public Health
OECD (2022) · OECD eBooks · doi:10.1787/40f65568-en · Cited by 276
Medical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
The future of precision medicine: potential impacts for health technology assessment
Love-Koh, J., Peel, A., Rejon-Parrilla, J. C., Ennis, K., Lovett, R., Manca, A., Chalkidou, A., Wood, H., & Taylor, M. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0686-6 · Cited by 131
Romero-Sanchiz, P., Nogueira-Arjona, R., García-Ruiz, A., Luciano, J. V., García Campayo, J., Gili, M., Botella, C., Baños, R., Castro, A., López-Del-Hoyo, Y., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172741 · Cited by 78
Metadata
- Authors
- Vallejo-Torres, L., García-Lorenzo, B., Castilla, I., Valcárcel-Nazco, C., García-Pérez, L., Linertová, R., Polentinos-Castro, E., & Serrano-Aguilar, P.
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 19
- Issue
- 5
- Pages
- 558-566
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2337377794
- Cited by
- 170
- References
- 3
- FWCI
- 27.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: On the Estimation of the Cost-Effectiveness Threshold: Why, What, How? https://app.cochat.ai/papers/10.1016/j.jval.2016.02.020
- The paper
- Vallejo-Torres, L., García-Lorenzo, B., Castilla, I., Valcárcel-Nazco, C., García-Pérez, L., Linertová, R., Polentinos-Castro, E., & Serrano-Aguilar, P. (2016). On the Estimation of the Cost-Effectiveness Threshold: Why, What, How? Value in Health. https://doi.org/10.1016/j.jval.2016.02.020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.